Table 2.
Tumor characteristics
| Patient no.a | Distribution of tumors in the thoracic region | Target tumor number | Target tumor location | Tumor size (mm) | |
|---|---|---|---|---|---|
| Before TACE | After TACE | ||||
| 1 | 19 lesions in bilateral lungs and 1 LN metastasis | 1 2 3 |
RSL #11R RIL |
36 37 29 |
32 23 21 |
| 2 | 1 lesion in right lung and 7 LN metastases | 4 5 |
#10L #5 |
26 26 |
23 21 |
| 3 | 3 lesions in right lung (pleura) and 4 LN metastases | 6 7 8 |
RSL RIL #7 |
24 27 39 |
21 24 34 |
| 4 | 31 lesions in bilateral lungs and no LN metastases | 9 10 11 |
RML RML RIL |
20 17 27 |
13 13 27 |
| 5 | 9 lesions in bilateral lungs and 2 LN metastases | 12 13 |
RSD LSD |
37 40 |
32 36 |
| 6 | More than 60 lesions in bilateral lungs and 11 LN metastases | 14 15 16 |
#4L #4R LLL |
23 38 30 |
22 29 32 |
| 7 | 4 lesions in bilateral lung and 2 LN metastasis | 17 18 19 |
#7 #12L LIL |
27 32 51 |
27 28 49 |
| 8 | No lung lesions and 5 LN metastases | 20 21 |
#10R RML |
26 30 |
26 29 |
| 9 | Multiple lesions in bilateral lungs and no LN metastasis | 22 23 24 |
RSL #10R RIL |
17 12 13 |
9 4 11 |
| 10 | 5 lesions in bilateral lungs and 6 LN metastases, | 25 26 27 |
#7 #4R #11R |
52 26 26 |
48 19 25 |
| 11 | 1 lesion in the right lung and 1 LN metastasis | 28 29 |
RML #4R |
31 35 |
20 33 |
| 12 | No lung lesions and 1 LN metastasis | 30 | #5 | 29 | 24 |
| 13 | No lung lesions and 1 LN metastasis | 31 | #10R | 24 | 21 |
| 14 | 16 bilateral lung lesions and 1 LN metastasis | 32 33 |
#10R RML |
33 16 |
29 12 |
LIL, left inferior lobe; LLL, left lingular lobe;LN, lymph node; LSD, left supradiaphragmatic; RIL, right inferior lobe; RML, right inferior lobe; RSD, right supradiaphragmatic; RSL, right left superior lobe; RSL, right superior lobe;TACE, transcatheter arterial chemoembolization.
a
Patient numbers do not match those of Figure 4.